Showing results (61-70 of 295) with videos related to
Sort By:
Pageof 30
The Journal of Pharmacology and Experimental Therapeutics|July 19, 2026
Xylazine's κ relatively potent opioid agonist activity is not shared with other US Food and Drug Administration-approved α2-adrenergic agonistsXi-Ping Huang, Brian E Krumm, Madigan L Bedard, et al.Cancer Discovery|April 3, 2021
The Future of Clinical Trial Design in OncologyAnna Spreafico, Aaron R Hansen, Albiruni R Abdul Razak, et al.Applied and Environmental Microbiology|May 1, 1987
Extensive degradation of Aroclors and environmentally transformed polychlorinated biphenyls by Alcaligenes eutrophus H850D L Bedard, R E Wagner, M J Brennan, et al.Urologic Oncology|October 24, 2015
Randomized controlled trials in testicular cancer: A demographic and quality assessmentMadhur Nayan, Viranda H Jayalath, Michael A S Jewett, et al.Biorxiv : the Preprint Server for Biology|March 18, 2026
Xylazine's κ opioid agonist activity is not shared with other FDA-approved α 2 -adrenergic agonistsXi-Ping Huang, Brian E Krumm, Madigan L Bedard, et al.JCO Precision Oncology|June 27, 2024
Clinical Utility of Tumor Next-Generation Sequencing Panel Testing to Inform Treatment Decisions for Patients With Advanced Solid Tumors in a Tertiary Care CenterLucia Bogdan, Ramy R Saleh, Lisa Avery, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Ocular toxicity of targeted therapiesDaniel J Renouf, Juan P Velazquez-Martin, Rand Simpson, et al.Chemical Research in Toxicology|October 22, 2002
Investigation of the role of lipoxygenase in bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lungLeanne L Bedard, Graeme B J Smith, Ken R Reid, et al.Critical Reviews in Oncology/Hematology|December 17, 2009
Brain metastases in HER2-positive breast cancer: the evolving role of lapatinibGianluca Tomasello, Philippe L Bedard, Evandro de Azambuja, et al.Applied and Environmental Microbiology|April 1, 1986
Rapid assay for screening and characterizing microorganisms for the ability to degrade polychlorinated biphenylsD L Bedard, R Unterman, L H Bopp, et al.Pageof 30